{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:46:27Z","timestamp":1762325187587,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00345-021-03901-4","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:05:58Z","timestamp":1641427558000},"page":"719-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of prior radiation on stage, differentiation, and survival in bladder cancer"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7854-2967","authenticated-orcid":false,"given":"Syed M.","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Chollet-Hinton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Holzbeierlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"3901_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.12.012","volume":"110","author":"L Murray","year":"2014","unstructured":"Murray L, Henry A, Hoskin P, Siebert FA, Venselaar J (2014) Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment technique. Radiother Oncol 110:213\u2013228","journal-title":"Radiother Oncol"},{"issue":"3","key":"3901_CR2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2006.05.016","volume":"66","author":"SL Liauw","year":"2006","unstructured":"Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD (2006) Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up. Int J Radiat Oncol Biol Phys 66(3):669\u2013673","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3901_CR3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.juro.2006.10.071","volume":"177","author":"S Boorjian","year":"2007","unstructured":"Boorjian S, Cowan JE, Konety BR, DuChane J, Tewari A, Carroll PR et al (2007) Bladder cancer incidence and risk factors in men with prostate cancer: results from cancer of the prostate strategic urologic research endeavor. J Urol 177(3):883\u2013888","journal-title":"J Urol"},{"issue":"5","key":"3901_CR4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.juro.2008.07.038","volume":"180","author":"AM Nieder","year":"2008","unstructured":"Nieder AM, Porter MP, Soloway MS (2008) Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a Population Based Cohort Study. J Urol 180(5):2005\u20132010","journal-title":"J Urol"},{"issue":"5","key":"3901_CR5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cncr.22083","volume":"107","author":"K Moon","year":"2006","unstructured":"Moon K, Stukenborg GJ, Keim J, Theodorescu D (2006) Cancer incidence after localized therapy for prostate cancer. Cancer 107(5):991\u2013998","journal-title":"Cancer"},{"key":"3901_CR6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/CMAR.S185867","volume":"11","author":"S Zhao","year":"2019","unstructured":"Zhao S, Xie Q, Yang R, Wang J, Zhang C, Luo L et al (2019) High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis. Cancer Manag Res 11:587\u2013598","journal-title":"Cancer Manag Res"},{"issue":"11","key":"3901_CR7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.celrep.2015.08.015","volume":"12","author":"AL Sherborne","year":"2015","unstructured":"Sherborne AL, Davidson PR, Yu K, Nakamura AO, Rashid M, Nakamura JL (2015) Mutational analysis of ionizing radiation induced neoplasms. Cell Rep 12(11):1915\u20131926","journal-title":"Cell Rep"},{"issue":"3","key":"3901_CR8","doi-asserted-by":"crossref","first-page":"152822","DOI":"10.1016\/j.prp.2020.152822","volume":"216","author":"S Au","year":"2020","unstructured":"Au S, Keyes M, Black P, Villamil CF, Tavassoli P (2020) Clinical and pathological characteristics of bladder cancer in post brachytherapy patients. Pathol Res Pract 216(3):152822","journal-title":"Pathol Res Pract"},{"issue":"5","key":"3901_CR9","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.juro.2010.01.014","volume":"183","author":"DS Yee","year":"2010","unstructured":"Yee DS, Shariat SF, Lowrance WT, Sterbis JR, Vora KC, Bochner BH et al (2010) Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer. J Urol 183(5):1751\u20131756","journal-title":"J Urol"},{"issue":"1","key":"3901_CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.juro.2007.08.157","volume":"179","author":"PJ Bostrom","year":"2008","unstructured":"Bostrom PJ, Soloway MS, Manoharan M, Ayyathurai R, Samavedi S (2008) Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy. J Urol 179(1):91\u201395","journal-title":"J Urol"},{"key":"3901_CR11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"SS Chang","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR et al (2016) Diagnosis and treatment of non-muscle invasice bladder cancer: AUA\/SUO guideline. J Urol 196:1021\u20131029","journal-title":"J Urol"},{"issue":"1","key":"3901_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.ju.0000163459.57305.a1","volume":"174","author":"K Chrouser","year":"2005","unstructured":"Chrouser K, Leibovich B, Bergstralh E, Zincke H, Blute M (2005) Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer. J Urol 174(1):107\u2013110","journal-title":"J Urol"},{"issue":"2 Suppl","key":"3901_CR13","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2307\/3578891","volume":"137","author":"K Mabuchi","year":"1994","unstructured":"Mabuchi K, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Preston DL (1994) Cancer incidence in atomic bomb survivors. Part I: use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res 137(2 Suppl):S1\u2013S16","journal-title":"Radiat Res"},{"issue":"5","key":"3901_CR14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2009.02.024","volume":"136","author":"J Luo","year":"2009","unstructured":"Luo J, Solimini NL, Elledge SJ (2009) Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136(5):823\u2013837","journal-title":"Cell"},{"issue":"5","key":"3901_CR15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","volume":"117","author":"JB Swann","year":"2007","unstructured":"Swann JB, Smyth MJ (2007) Immune surveillance of tumors. J Clin Invest 117(5):1137\u20131146","journal-title":"J Clin Invest"},{"key":"3901_CR16","first-page":"6","volume":"23","author":"A Torgovnick","year":"2015","unstructured":"Torgovnick A, Schumacher B (2015) DNA repair mechanisms in cancer development and therapy. Front Genet 23:6","journal-title":"Front Genet"},{"issue":"1","key":"3901_CR17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1464-410X.2006.06182.x","volume":"98","author":"JS Sandhu","year":"2006","unstructured":"Sandhu JS, Vickers AJ, Bochner B, Donat SM, Herr HW, Dalbagni G (2006) Clinical characteristics of bladder cancer in patients previously treated with radiation for prostate cancer. BJU Int 98(1):59\u201362","journal-title":"BJU Int"},{"issue":"12","key":"3901_CR18","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1586\/era.10.131","volume":"10","author":"G Bartsch","year":"2010","unstructured":"Bartsch G, Mitra AP, Cote RJ (2010) Expression profiling for bladder cancer: strategies to uncover prognostic factors. Expert Rev Anticancer Ther 10(12):1945\u20131954","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"3901_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J et al (2014) Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25(2):152\u2013165","journal-title":"Cancer Cell"},{"issue":"1","key":"3901_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ccell.2016.05.004","volume":"30","author":"J Hedegaard","year":"2016","unstructured":"Hedegaard J, Lamy P, Nordentoft I, Algaba F, H\u00f8yer S, Ulh\u00f8i BP et al (2016) Comprehensive transcriptional analysis of early-stage urothelial carcinoma. Cancer Cell 30(1):27\u201342","journal-title":"Cancer Cell"},{"issue":"7","key":"3901_CR21","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/labinvest.2008.27","volume":"88","author":"T Majewski","year":"2008","unstructured":"Majewski T, Lee S, Jeong J, Yoon D-S, Kram A, Kim M-S et al (2008) Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy. Lab Invest 88(7):694","journal-title":"Lab Invest"},{"key":"3901_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2021.06.007","author":"S Ourfail","year":"2021","unstructured":"Ourfail S, Matillon X, Ricci E et al (2021) Prognostic implications of treatment delays for patients with non-muscle-invasive bladder cancer. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2021.06.007","journal-title":"Eur Urol Focus"},{"issue":"7","key":"3901_CR23","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cncr.20140","volume":"100","author":"J Warwick","year":"2004","unstructured":"Warwick J, Tab\u00e0r L, Vitak B, Duffy SW (2004) Time-dependent effects on survival in breast carcinoma. Cancer 100(7):1331\u20131336","journal-title":"Cancer"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-021-03901-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-021-03901-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-021-03901-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T13:55:01Z","timestamp":1648216501000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-021-03901-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3901"],"URL":"https:\/\/doi.org\/10.1007\/s00345-021-03901-4","relation":{},"ISSN":["1433-8726"],"issn-type":[{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"5 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable due to use of public database.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable due to use of public database.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}